NanoVibronix, Inc. (NAOV)
USD 2.34
(0.86%)
USD 2.34
(0.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.53 Million USD | 820.36% |
| 2022 | 167 Thousand USD | -78.31% |
| 2021 | 770 Thousand USD | 259.81% |
| 2020 | 214 Thousand USD | -23.84% |
| 2019 | 281 Thousand USD | 75.63% |
| 2018 | 160 Thousand USD | 5.96% |
| 2017 | 151 Thousand USD | 7.09% |
| 2016 | 141 Thousand USD | 43.88% |
| 2015 | 98 Thousand USD | -10.91% |
| 2014 | 110 Thousand USD | -8.33% |
| 2013 | 120 Thousand USD | 3.45% |
| 2012 | 116 Thousand USD | 78.46% |
| 2011 | 65 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 428 Thousand USD | -35.54% |
| 2024 Q1 | 664 Thousand USD | -9.91% |
| 2023 Q2 | 216 Thousand USD | -8.09% |
| 2023 Q1 | 235 Thousand USD | 178.33% |
| 2023 Q3 | 349 Thousand USD | 61.57% |
| 2023 Q4 | 737 Thousand USD | 111.17% |
| 2023 FY | 1.53 Million USD | 820.36% |
| 2022 Q1 | 106 Thousand USD | -58.75% |
| 2022 Q2 | 281 Thousand USD | 165.09% |
| 2022 Q3 | 80 Thousand USD | -71.53% |
| 2022 Q4 | -300 Thousand USD | -475.0% |
| 2022 FY | 167 Thousand USD | -78.31% |
| 2021 Q1 | 77 Thousand USD | 196.15% |
| 2021 Q3 | 228 Thousand USD | 9.62% |
| 2021 Q4 | 257 Thousand USD | 12.72% |
| 2021 Q2 | 208 Thousand USD | 170.13% |
| 2021 FY | 770 Thousand USD | 259.81% |
| 2020 Q4 | 26 Thousand USD | -73.74% |
| 2020 Q2 | 38 Thousand USD | -25.49% |
| 2020 FY | 214 Thousand USD | -23.84% |
| 2020 Q1 | 51 Thousand USD | 296.15% |
| 2020 Q3 | 99 Thousand USD | 160.53% |
| 2019 Q1 | 53 Thousand USD | 178.95% |
| 2019 FY | 281 Thousand USD | 75.63% |
| 2019 Q4 | -26 Thousand USD | -155.32% |
| 2019 Q3 | 47 Thousand USD | -77.29% |
| 2019 Q2 | 207 Thousand USD | 290.57% |
| 2018 Q3 | 8000.00 USD | -89.61% |
| 2018 FY | 160 Thousand USD | 5.96% |
| 2018 Q1 | 55 Thousand USD | 44.74% |
| 2018 Q2 | 77 Thousand USD | 40.0% |
| 2018 Q4 | 19 Thousand USD | 137.5% |
| 2017 FY | 151 Thousand USD | 7.09% |
| 2017 Q1 | 36 Thousand USD | -5.26% |
| 2017 Q2 | 34 Thousand USD | -5.56% |
| 2017 Q3 | 43 Thousand USD | 26.47% |
| 2017 Q4 | 38 Thousand USD | -11.63% |
| 2016 Q1 | 30 Thousand USD | 20.0% |
| 2016 FY | 141 Thousand USD | 43.88% |
| 2016 Q4 | 38 Thousand USD | 11.76% |
| 2016 Q3 | 34 Thousand USD | -15.0% |
| 2016 Q2 | 40 Thousand USD | 33.33% |
| 2015 FY | 98 Thousand USD | -10.91% |
| 2015 Q1 | 19 Thousand USD | -53.66% |
| 2015 Q2 | 24 Thousand USD | 26.32% |
| 2015 Q3 | 30 Thousand USD | 25.0% |
| 2015 Q4 | 25 Thousand USD | -16.67% |
| 2014 Q4 | 41 Thousand USD | 510.0% |
| 2014 FY | 110 Thousand USD | -8.33% |
| 2014 Q1 | 40 Thousand USD | 2100.0% |
| 2014 Q2 | 39 Thousand USD | -2.5% |
| 2014 Q3 | -10 Thousand USD | -125.64% |
| 2013 Q4 | -2000.00 USD | 91.3% |
| 2013 Q3 | -23 Thousand USD | 0.0% |
| 2013 FY | 120 Thousand USD | 3.45% |
| 2013 Q1 | 22 Thousand USD | -45.0% |
| 2012 FY | 116 Thousand USD | 78.46% |
| 2012 Q4 | 40 Thousand USD | 33.33% |
| 2012 Q3 | 30 Thousand USD | 0.0% |
| 2011 FY | 65 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 39.725% |
| BrainsWay Ltd. | 23.09 Million USD | 93.344% |
| Cerus Corporation | 86.4 Million USD | 98.221% |
| Envoy Medical, Inc. | -473 Thousand USD | 424.947% |
| electroCore, Inc. | 13.22 Million USD | 88.379% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -2419.672% |
| IceCure Medical Ltd | 1.3 Million USD | -18.231% |
| Inogen, Inc. | 126.69 Million USD | 98.787% |
| OrthoPediatrics Corp. | 111.25 Million USD | 98.618% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 125.405% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 3347.0% |
| MaxCyte, Inc. | 36.54 Million USD | 95.794% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -236.68% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1706.96% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.684% |
| PAVmed Inc | -3.96 Million USD | 138.735% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 128.022% |
| RxSight, Inc. | 53.76 Million USD | 97.141% |
| Sight Sciences, Inc. | 69.17 Million USD | 97.778% |
| SI-BONE, Inc. | 109.42 Million USD | 98.595% |
| TELA Bio, Inc. | 40.11 Million USD | 96.168% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 98.988% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 81.417% |
| Acutus Medical, Inc. | -3.13 Million USD | 148.996% |
| Talis Biomedical Corporation | 371 Thousand USD | -314.286% |
| Spectral AI, Inc. | 7.88 Million USD | 80.495% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 123.316% |
| CVRx, Inc. | 33.03 Million USD | 95.348% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -107.836% |
| Bioventus Inc. | 328.19 Million USD | 99.532% |
| Venus Concept Inc. | 52.16 Million USD | 97.054% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 90.337% |
| LivaNova PLC | 771.25 Million USD | 99.801% |
| 908 Devices Inc. | 25.32 Million USD | 93.93% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.505% |
| Nemaura Medical Inc. | -1.47 Million USD | 204.105% |
| NeuroPace, Inc. | 48.12 Million USD | 96.806% |
| LENSAR, Inc. | 21.1 Million USD | 92.718% |
| Apyx Medical Corporation | 14.12 Million USD | 89.116% |
| Cutera, Inc. | 41.49 Million USD | 96.296% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 91.674% |
| BioSig Technologies, Inc. | 18 Thousand USD | -8438.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 98.509% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 88.71% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.827% |
| Axonics, Inc. | 274.55 Million USD | 99.44% |
| Outset Medical, Inc. | 29 Million USD | 94.7% |
| IRIDEX Corporation | 21.8 Million USD | 92.952% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 97.837% |
| IRadimed Corporation | 50.15 Million USD | 96.936% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -435.54% |
| INVO Bioscience, Inc. | 1.08 Million USD | -41.511% |
| Telesis Bio, Inc. | 16.95 Million USD | 90.932% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 98.637% |
| Varex Imaging Corporation | 256.9 Million USD | 99.402% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.062% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 478.571% |
| Pulmonx Corporation | 50.75 Million USD | 96.972% |
| Dynatronics Corporation | 7.63 Million USD | 79.869% |
| Modular Medical, Inc. | -768 Thousand USD | 300.13% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 72.296% |
| Semler Scientific, Inc. | 61.2 Million USD | 97.489% |
| InMode Ltd. | 411.34 Million USD | 99.626% |
| Bruker Corporation | 1.51 Billion USD | 99.899% |
| Cytosorbents Corporation | 22.39 Million USD | 93.136% |
| DexCom, Inc. | 2.28 Billion USD | 99.933% |
| Align Technology, Inc. | 2.71 Billion USD | 99.943% |
| Viveve Medical, Inc. | 620 Thousand USD | -147.903% |
| ZimVie Inc. | 290.38 Million USD | 99.471% |
| Movano Inc. | -158 Thousand USD | 1072.785% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 98.595% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1706.96% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.582% |
| Profound Medical Corp. | 4.51 Million USD | 65.951% |
| Insulet Corporation | 1.15 Billion USD | 99.867% |
| enVVeno Medical Corporation | -546 Thousand USD | 381.502% |
| Surmodics, Inc. | 93.05 Million USD | 98.348% |
| iCAD, Inc. | 14.53 Million USD | 89.426% |
| Nuwellis, Inc. | 4.98 Million USD | 69.155% |
| Biotricity, Inc. | 8.35 Million USD | 81.607% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.537% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 528.066% |
| InspireMD, Inc. | 1.8 Million USD | 14.942% |
| PAVmed Inc. | -3.96 Million USD | 138.735% |
| BIOLASE, Inc. | 16.72 Million USD | 90.81% |
| Beyond Air, Inc. | -1.3 Million USD | 217.598% |
| FONAR Corporation | 45.14 Million USD | 96.595% |
| AxoGen, Inc. | 127.87 Million USD | 98.798% |
| Vivani Medical, Inc. | -357 Thousand USD | 530.532% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.212% |
| Inari Medical, Inc. | 434.56 Million USD | 99.646% |
| UFP Technologies, Inc. | 112.22 Million USD | 98.63% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -12177.338% |
| Tenon Medical, Inc. | 1.24 Million USD | -23.852% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1997.531% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 41.494% |
| AdaptHealth Corp. | 479.56 Million USD | 99.68% |
| Sintx Technologies, Inc. | 1.84 Million USD | 16.603% |
| Quanterix Corporation | 70.64 Million USD | 97.824% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 478.571% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 89.068% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 97.088% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.003% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 65.484% |
| NeuroMetrix, Inc. | 3.94 Million USD | 61.063% |
| Hyperfine, Inc. | 4.75 Million USD | 67.69% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 98.563% |
| Biomerica, Inc. | 611 Thousand USD | -151.555% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 96.313% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 296.81% |
| Silk Road Medical, Inc | 127.08 Million USD | 98.791% |